Bodmer Mark
- SEC CIK
- 0001738885
No open-market purchases or sales filed in the past year.
Current role at each company
- EVLO Evelo Biosciences, Inc.CSO, President of R&Das of Nov 8, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bodmer Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2023 (view filing)8:32 PM ET | Nov 8 | Same day | Bodmer MarkCSO, President of R&D | SSale | −3.16K | $0.33 | −$1.04K | −10.9%25.7K after | 10b5-1 |
| Nov 3, 2023 (view filing)4:12 PM ET | Nov 2 | 1 day | Bodmer MarkCSO, President of R&D | SSale | −6.85K | $0.33 | −$2.26K | −23.5%22.3K after | 10b5-1 |
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | Bodmer MarkCSO, President of R&D | SSale | −3.13K | $9.51 | −$29.7K | −15.8%16.6K after | 10b5-1 |
| Jun 12, 2023 (view filing)4:01 PM ET | May 23 | 20 daysLate | Bodmer MarkCSO, President of R&D | SSale | −22.6K | $0.1418 | −$3.20K | −7.9%262.6K after | 10b5-1 |
| May 10, 2023 (view filing)9:31 PM ET | May 8 | 2 days | Bodmer MarkCSO, President of R&D | SSale | −68.0K | $0.1255 | −$8.54K | −19.3%285.1K after | 10b5-1 |